Vertex Pharmaceuticals (VRTX)

Equity Ratio

73.83%

Quarterly · Period ending:

VRTX logo

VRTX Equity Ratio

Latest reported73.83%
VRTX Quarterly Equity Ratio (56.52% → 73.83%)
High-resolution chart · PNG

VRTX equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Equity Ratio — Quarterly
Period endingEquity Ratio
73.8347%
73.1068%
71.3994%
69.6589%
71.4549%
72.0976%
72.8241%
70.2822%
73.3888%
77.5444%
77.3438%
76.0041%
76.0236%
76.0628%
76.6502%
77.9917%
76.5842%
76.5076%
75.1908%
75.5282%
75.2465%
74.1247%
73.9188%
71.9672%
73.6%
72.6584%
73.1534%
69.9096%
72.0834%
72.1875%
71.0099%
62.8915%
61.9605%
60.7405%
57.2073%
56.0005%
50.8667%
50.9046%
39.9678%
39.2173%
38.4998%
38.4693%
37.6432%
37.8862%
37.6974%
45.0848%
46.013%
48.0409%
55.3526%
56.0226%
58.4899%
48.9744%
51.172%
31.189%
36.2115%
37.8007%
39.8399%
39.6658%
35.6961%
27.7133%
17.4437%
25.4583%
29.2083%
34.4179%
50.0021%
55.9572%
56.0651%
38.6875%
50.6333%
45.1407%
24.363%
32.7752%
24.714%
34.205%
45.1048%
50.6809%
54.474%
60.029%
54.8987%
56.2868%
27.978%
44.3931%
43.5659%
24.2132%
20.5993%
-1.7535%
6.4975%
12.9396%
17.6737%
23.4756%
26.6209%
31.1417%
39.8139%
47.6337%
46.4107%
49.119%
50.7488%
51.4111%
51.382%
51.6373%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.